Bill Text: TX HB4332 | 2023-2024 | 88th Legislature | Enrolled


Bill Title: Relating to the redistribution of donated prepackaged prescription drugs.

Spectrum: Partisan Bill (Republican 3-0)

Status: (Passed) 2023-06-12 - Effective on 9/1/23 [HB4332 Detail]

Download: Texas-2023-HB4332-Enrolled.html
 
 
  H.B. No. 4332
 
 
 
 
AN ACT
  relating to the redistribution of donated prepackaged prescription
  drugs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 442.001, Health and Safety Code, is
  amended by adding Subdivision (6-a) to read as follows:
               (6-a) "Prepackage" means the act of repackaging and
  relabeling varying quantities of prescription drugs from a
  manufacturer's original commercial container into a prescription
  container, unit-dose packaging, or a multi-compartment container
  for a pharmacist to dispense to a consumer.
         SECTION 2.  Subchapter B, Chapter 442, Health and Safety
  Code, is amended by adding Section 442.0515 to read as follows:
         Sec. 442.0515.  REDISTRIBUTION OF DONATED PREPACKAGED
  PRESCRIPTION DRUGS. (a) A participating provider may dispense to a
  recipient donated prescription drugs that are prepackaged and
  labeled in accordance with this section and rules adopted by the
  Texas State Board of Pharmacy.
         (b)  A prepackaged prescription drug a participating
  provider dispenses to a recipient must contain a label that
  includes:
               (1)  the drug's brand name or, for a generic version of
  the drug, the drug's generic name and the manufacturer or
  distributor of the drug;
               (2)  the amount of the drug in a given dose;
               (3)  the drug's lot number;
               (4)  the earliest expiration date of the drug for that
  drug lot number; and
               (5)  the quantity of any drug the provider dispenses in
  more than one dose.
         (c)  A participating provider shall maintain a record of each
  prepackaged prescription drug dispensed to a recipient. The record
  must include:
               (1)  the drug's name, the amount of the drug in a given
  dose, and the dosage size or frequency;
               (2)  the provider's lot number for that drug;
               (3)  the drug's manufacturer or distributor;
               (4)  the manufacturer's lot number for that drug;
               (5)  the expiration dates of the drug from that drug's
  lot number;
               (6)  the quantity of the drug in each prepackaged unit;
               (7)  the number of prepackaged units that include the
  drug;
               (8)  the date the drug was prepackaged;
               (9)  the name, initials, or written or electronic
  signature of the individual who prepackaged the drug; and
               (10)  the written or electronic signature of the
  pharmacist responsible for the drug's prepackaging.
         SECTION 3.  As soon as practicable after the effective date
  of this Act, the Texas State Board of Pharmacy shall adopt any rules
  necessary to implement the changes in law made by this Act.
         SECTION 4.  This Act takes effect September 1, 2023.
 
 
  ______________________________ ______________________________
     President of the Senate Speaker of the House     
 
 
         I certify that H.B. No. 4332 was passed by the House on April
  28, 2023, by the following vote:  Yeas 140, Nays 4, 2 present, not
  voting.
 
  ______________________________
  Chief Clerk of the House   
 
 
         I certify that H.B. No. 4332 was passed by the Senate on May
  17, 2023, by the following vote:  Yeas 31, Nays 0.
 
  ______________________________
  Secretary of the Senate    
  APPROVED:  _____________________
                     Date          
   
            _____________________
                   Governor       
feedback